NearWave
Pre-clinicalA breakthrough, safe, non-invasive device using fdNIRS to assess vital biomarkers, including tissue oxygen saturation and concentrations of hemoglobin.
Founded
2018
Focus
DiagnosticsDigital Health
About
A breakthrough, safe, non-invasive device using fdNIRS to assess vital biomarkers, including tissue oxygen saturation and concentrations of hemoglobin.
Funding History
1Total raised: $2.5M
Seed$2.5MUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2018
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile